Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AN 207

Known as: AN-207 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
We determined by immunohistochemistry the presence of LHRH receptors in surgical specimens of human non-Hodgkin's lymphomas (NHL… Expand
Is this relevant?
2005
2005
OBJECTIVE To treat experimental human endometrial cancers based on targeted chemotherapy with the cytotoxic luteinizing hormone… Expand
Is this relevant?
Review
2005
Review
2005
Chemotherapy is one of the main modalities in the therapy of cancer. However, an improvement in the efficacy and a reduction in… Expand
Is this relevant?
2002
2002
The efficacy of therapy with targeted cytotoxic luteinizing hormone-releasing hormone (LHRH) analog AN-207 consisting of… Expand
Is this relevant?
2000
2000
A highly potent derivative of doxorubicin, 2-pyrrolinodoxorubicin (AN-201), was linked to [D-Lys6]luteinizing hormone-releasing… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
1999
Review
1999
In view of non-specific toxicity of most chemotherapeutic agents against normal cells, the development of targeted chemotherapy… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
1999
1999
OBJECTIVE The aim of the study was to investigate the effects of the cytotoxic analog of luteinizing hormone-releasing hormone AN… Expand
Is this relevant?
1999
1999
Receptors for luteinizing hormone–releasing hormone (LH‐RH) are found in about 50% of human breast carcinomas. A highly potent… Expand
Is this relevant?
1999
1999
Receptors for luteinizing hormone‐releasing hormone (LH‐RH) found in prostate cancers might be used for targeting of… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Doxorubicin (DOX) and its daunosamine-modified derivative, 2-pyrrolino-DOX, which is 500-1000 times more active than DOX, were… Expand
Is this relevant?